Search Results - Isabel Rauscher

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Pre-test 68Ga-PSMA-ligand PET/CT positivity in early biochemical recurrent prostate cancer after radical prostatectomy—validation of a prediction model by Pia Kraft, Tobias Maurer, Andrei Gafita, Markus Krönke, Bernhard Haller, Wolfgang A. Weber, Matthias Eiber, Isabel Rauscher

    Published in EJNMMI Research (2020-02-01)
    Get full text
    Article


  2. 2

    Influence of fasting prior to 18F-rhPSMA-7.3 (Flotufolastat F-18) PET/CT on biodistribution and tumor uptake by Sonia Grigorascu, Thomas Langbein, Isabel Rauscher, Calogero D’Alessandria, Tobias Maurer, Türkay Hekimsoy, Wolfgang A Weber, Matthias Eiber

    Published in EJNMMI Research (2024-11-01)
    Get full text
    Article


  3. 3

    Matched-pair analysis of mCRPC patients receiving 177Lu-labeled PSMA-targeted radioligand therapy in a 4-week versus 6-week treatment interval by Amir Karimzadeh, Charlotte-Sophie Hecker, Matthias M. Heck, Robert Tauber, Calogero D’Alessandria, Wolfgang A. Weber, Matthias Eiber, Isabel Rauscher

    Published in EJNMMI Research (2024-10-01)
    Get full text
    Article


  4. 4

    Biochemical failure-free survival of 18F-rhPSMA-7 and 18F-flotufolastat PET-guided salvage radiotherapy for patients with recurrent prostate cancer by Marco M. E. Vogel, Isabel Rauscher, Jürgen E. Gschwend, Türkay Hekimsoy, Nicola Gabler, Charlotte Olufs, Calogero D’Alessandria, Jan C. Peeken, Stephanie E. Combs, Matthias Eiber

    Published in Scientific Reports (2025-01-01)
    Get full text
    Article


Search Tools: